$HNGE

Insight Holdings Group, LLC sold $121.5M of HNGE (indirect holdings)

Insight Holdings Group, LLC sold 1,466,667 indirectly-held shares of Hinge Health, Inc. (HNGE) at an average of $82.83 ($81.30–$84.59, $121.49M total) across 20 trades on 2026-06-29 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Insight Holdings Group, LLC
Published Jun 30, 2026, 1:27 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 30, 2026, 1:31 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$HNGE
Neutral
medium confidence
Mentioned
$HNGE
Relevance
7/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$HNGENeutralLow
01

Why it matters

Traders may monitor for short-term sentiment/flow effects from a large, same-day open-market sale, but the 10b5-1 designation reduces interpretive weight.

02

Market read

A large 10% owner open-market sale (10b5-1) is disclosed for HNGE, which can influence near-term sentiment but provides no new company fundamentals.

03

What to watch

The filing shows the holder’s position goes to zero, which can matter for positioning/overhang, but the article lacks any accompanying narrative about performance, valuation, or future plans.

Relevance 7/10Novelty 6/10Timing: after-hours/next-session reaction to the 2026-06-29 Form 4 filing

Background

The article is an SEC Form 4 insider transaction disclosure for Hinge Health, Inc. (HNGE) by a 10% owner via indirect holdings.

Company-level read

Ticker impact

$HNGENeutralMedium confidence
Context

Hinge Health disclosed an SEC Form 4 showing 10% owner Insight Holdings Group sold 1,466,667 shares in open-market trades on 2026-06-29.

Expected impact

Likely limited immediate price impact; any effect would be sentiment/flow-driven around the filing and subsequent trading days.

Evidence & confidence

The filing is a primary-source Form 4 with a pre-arranged 10b5-1 plan and the holder ends with 0 shares, but the text provides no new operational or financial guidance.

Market effects

Minimal; this is company-specific insider selling rather than a sector-wide regulatory or demand signal.

None indicated; filing is US-based and does not reference cross-market events.

None indicated; no international operations or global deal terms mentioned.

Counterpoint

Because the sale is explicitly under a pre-arranged 10b5-1 plan, the transaction may be routine liquidity rather than a bearish signal.

Key entities

  • Hinge Health, Inc.

    Subject of the Form 4; 10% owner Insight Holdings Group sold 1,466,667 shares on 2026-06-29 under a 10b5-1 plan.

  • Insight Holdings Group, LLC

    Reporter of the Form 4; sold shares in open-market trades and reports 0 shares after the transaction.

Related articles

$HNGEHighAI 9/10

Why is Hinge Health stock surging today?

Hinge Health (HNGE) shares rose 11.6% after the company reported Q2 2026 revenue of $212.8M (+53% YoY) and non-GAAP diluted EPS of $0.59 vs $0.13 consensus. Free cash flow exceeded $100M. Hinge raised FY2026 revenue guidance to $818M-$824M and Q3 guidance to $223M-$225M, and agreed to buy Cylinder Health for $105M cash. Analysts lifted price targets.

$HNGELowAI 8/10

Jim Cramer Says Hinge Health “Delivered a True Blowout Set of Numbers”

On Jim Cramer’s “Mad Money,” he discussed Hinge Health (NYSE:HNGE) after the company reported strong results. Cramer said revenue rose 47% year over year, margins beat expectations, and earnings topped estimates. He noted management raised current-quarter guidance and substantially lifted the full-year forecast, and the stock jumped about 10% in one session, then traded sideways.